Medline Angiographic Syringe Injury Lawsuit Lawyers

Medline Recalls Millions of Angiographic Syringes Following Serious Safety Concerns

What Parker Waichman LLP Found

• Millions of angiographic syringes were recalled due to loose connection risks
• FDA issued a Class I recall, indicating serious injury or death risk
• Reports included air injection into patients and clinician biohazard exposure
• FDA cited manufacturing violations and quality control failures
• Patients nationwide may have been affected by recalled procedure kits

A major medical device recall involving millions of angiographic control syringes has raised significant safety concerns for patients, hospitals, and healthcare providers nationwide. Medline, a large medical supplier based in Illinois, recalled more than four million syringes and over one million procedure kits after identifying a potentially dangerous defect. The U.S. Food and Drug Administration classified this action as a Class I recall, which is the most serious type of recall issued when there is a reasonable probability that a product may cause serious injury or death.

These devices were widely used in cardiac catheterization labs and interventional radiology settings for administering radiographic contrast media through intravenous or intra-arterial procedures. The recall was triggered by reports of loose connections or complete disconnections between the syringe and manifold. This type of failure during a medical procedure can introduce air into a patient’s bloodstream or expose healthcare workers to biohazard risks.

The FDA also issued a warning letter citing multiple manufacturing and quality control violations. The agency indicated that it was not satisfied with Medline’s responses to earlier safety concerns. The combination of device defects, reported injuries, and regulatory violations has raised serious questions about patient safety and corporate accountability.

Patients who underwent procedures involving these recalled devices may face unexpected complications. In many situations, individuals may not even realize they were exposed to a recalled device until complications arise later. These developments have led to increased scrutiny and potential legal claims involving defective medical devices and product liability.

Understanding the Defective Syringe Risk and Why It Matters

Angiographic control syringes play a critical role in diagnostic and interventional procedures. These devices are used to inject contrast dye into blood vessels, allowing physicians to visualize arteries, veins, and organs. Because these procedures often involve the heart, brain, or major blood vessels, device reliability is essential.

The recalled syringes were reportedly prone to loose connections between the syringe and manifold. This type of failure can create dangerous conditions during a medical procedure. When a syringe disconnects, air can enter the system and potentially be injected into a patient’s bloodstream. Air embolisms can lead to serious complications, including stroke, heart attack, or even death.

Another risk involves sudden disconnection during high-pressure injections. If the connection fails, contrast media or bodily fluids may spray or leak, creating biohazard exposure risks for clinicians. These incidents can also interrupt critical procedures, forcing doctors to act quickly under emergency conditions.

The FDA reported at least four injuries associated with these devices. Additional complaints included an incident involving the injection of air into a patient and another involving exposure to bodily fluids. These incidents highlight the severity of the potential risk.

Because these syringes were included in procedure kits, they may have been used in hospitals across the country. This broad distribution increases the likelihood that patients nationwide may have been affected.

FDA Warning Letter Highlights Manufacturing Violations

In addition to the recall, the FDA issued a warning letter citing several regulatory violations. These violations involved quality control, complaint handling, manufacturing processes, and design verification.

The FDA noted that Medline failed to properly address an increase in complaints that began in June 2023. According to the agency, the company’s risk assessments were inconsistent and did not adequately address the root cause of the problem. The defect was believed to be linked to excess silicone in the device components.

The FDA also criticized Medline for failing to implement corrective actions to prevent recurrence. This type of failure raises concerns about whether the company took sufficient steps to protect patients.

Another issue involved manufacturing cleanliness. The FDA identified more than 100 complaints related to foreign matter, including hair or debris inside device packaging. These complaints spanned from December 2023 through December 2025. Contamination of medical devices presents serious infection risks and indicates potential problems with manufacturing environments.

The FDA further noted that Medline failed to maintain proper equipment cleaning and maintenance schedules. These failures can affect product quality and increase the likelihood of defective devices reaching patients.

Design Verification Concerns Raise Additional Questions

The FDA also identified problems related to device design verification. Specifically, the agency found that Medline failed to demonstrate that certain connector components met updated standards after design changes.

Design verification is a critical part of medical device safety. Manufacturers must confirm that updated components function properly under real-world conditions. Failure to properly verify design changes can lead to unexpected device failures during medical procedures.

The FDA expressed concern that Medline did not adequately demonstrate compliance with updated standards. This issue raises questions about whether proper testing was conducted before distributing these devices.

When medical devices fail due to inadequate design verification, patients may face serious health risks. These failures also increase the potential for legal claims involving defective medical devices.

FDA Threatens Regulatory Action

The FDA concluded its warning letter by urging Medline to take prompt corrective action. The agency warned that failure to address the violations could result in regulatory enforcement measures.

Potential regulatory actions include product seizure, injunctions, and civil money penalties. The FDA also indicated that other federal agencies may consider these issues when evaluating federal contracts.

Regulatory warnings of this nature often signal serious concerns about manufacturing practices and patient safety. When a recall is combined with regulatory violations, it can strengthen claims that defective devices were distributed to healthcare providers.

Who May Be Affected by the Recall

Patients who underwent angiographic procedures, cardiac catheterizations, or interventional radiology procedures may have been exposed to these recalled devices. Because these syringes were included in procedure kits, patients may not know whether the devices were used during their treatment.

Healthcare providers may also have been affected. Reports of biohazard exposure highlight the potential risk to clinicians and hospital staff.

Individuals who experienced complications following procedures involving contrast injection may wish to investigate whether a recalled device was used. Symptoms of complications may include chest pain, neurological symptoms, infection, or unexpected procedural complications.

Legal Claims Involving Defective Medical Devices

Medical device manufacturers have a responsibility to produce safe products and warn users of potential risks. When defective devices cause harm, injured individuals may have the right to pursue legal claims.

Potential claims may involve:

• Defective design
• Manufacturing defects
• Failure to warn
• Negligence
• Quality control failures

These claims often focus on whether the manufacturer failed to identify risks, correct defects, or properly test devices before distribution.

When a recall is classified as Class I, it indicates a serious risk of injury or death. This classification may play a significant role in legal claims involving recalled devices.

Angiographic Syringe Injury Lawsuit FAQs

What is a Class I medical device recall?

A Class I recall is the most serious type of recall issued by the FDA. It means there is a reasonable probability that the device could cause serious injury or death. When a Class I recall occurs, healthcare providers are typically instructed to stop using the device immediately.

How do I know if a recalled syringe was used during my procedure?

Patients may need to request medical records from the hospital or healthcare provider. These records may identify the devices used during a procedure. Healthcare providers may also notify patients if they were exposed to a recalled device.

What injuries could be linked to defective angiographic syringes?

Potential injuries may include air embolism, infection, procedural complications, stroke, heart attack, or exposure to contaminated devices. The type of injury depends on the circumstances of the procedure and the device failure.

Can healthcare workers file claims?

Healthcare workers who experienced biohazard exposure or injury may also have legal rights. Exposure incidents may involve bodily fluids, contamination, or procedural accidents.

What compensation may be available in a medical device lawsuit?

Compensation may include medical expenses, lost wages, pain and suffering, and other damages. Each case depends on the facts and severity of the injury.

How long do I have to file a lawsuit?

Deadlines vary depending on state law. These deadlines are known as statutes of limitations. It is important to investigate claims promptly to preserve legal rights.

Contact Parker Waichman LLP For A Free Case Review

If you or a loved one underwent a cardiac catheterization or radiology procedure and later experienced complications, you may have been affected by recalled angiographic syringes. Defective medical devices can lead to serious injuries, unexpected complications, and long-term health consequences. Parker Waichman LLP is investigating claims involving recalled medical devices nationwide.

Parker Waichman LLP offers free consultations for individuals who may have been affected. There are no upfront fees, and you pay nothing unless your case is successful.

Call 1-800-YOUR-LAWYER (1-800-968-7529) today to receive your free consultation and to learn more about your legal options. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.